Antagonist of peroxisome proliferator-activated receptor γ induces cerebellar amyloid-β levels and motor dysfunction in APP/PS1 transgenic mice

Biochemical and Biophysical Research Communications

Volumn 384, Issue 3, 2009, Pages 357-361

  Du, Jing ^a   Sun, Bing ^a   Chen, Kui ^b   Fan, Li ^b,c   Wang, Zhao ^a  

^a Tsinghua University   (China)

^b ANHUI MEDICAL UNIVERSITY   (China)

^c Albert Starr Academic Center   (United States)

Author keywords

Alzheimer's disease; Amyloid ; Cerebellar dysfunction; Cerebellum; GW9662; Insulin degrading enzyme; Peroxisome proliferator activated receptor

Indexed keywords

2 CHLORO 5 NITROBENZANILIDE; AMYLOID BETA PROTEIN; BRAIN ENZYME; INSULINASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PRESENILIN 1;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CEREBELLUM; CONTROLLED STUDY; MOTOR DYSFUNCTION; MOUSE; NEUROPATHOLOGY; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN INDUCTION; RAT; STEADY STATE; TRANSGENIC MOUSE;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; AMYLOID BETA-PROTEIN PRECURSOR; ANILIDES; ANIMALS; CEREBELLUM; DISEASE MODELS, ANIMAL; HIPPOCAMPUS; MICE; MICE, TRANSGENIC; MOTOR ACTIVITY; MOVEMENT DISORDERS; PPAR GAMMA;

ANIMALIA; MUS MUSCULUS;

EID: 65749091484     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.04.148     Document Type: Article

References (21)

1. Small G.W., Rabins P.V., Barry P.P., Buckholtz N.S., DeKosky S.T., Ferris S.H., Finkel S.I., Gwyther L.P., Khachaturian Z.S., Lebowitz B.D., McRae T.D., Morris J.C., Oakley F., Schneider L.S., Streim J.E., Sunderland T., Teri L.A., and Tune L.E. Diagnosis and treatment of Alzheimer disease and related disorders. Consensus statement of the American Association for Geriatric Psychiatry, the Alzheimer's Association, and the American Geriatrics Society. JAMA 278 (1997) 1363-1371
2. Greene J.D., Baddeley A.D., and Hodges J.R. Analysis of the episodic memory deficit in early Alzheimer's disease: evidence from the doors and people test. Neuropsychologia 34 (1996) 537-551
3. Pillon B., Deweer B., Agid Y., and Dubois B. Explicit memory in Alzheimer's, Huntington's, and Parkinson's diseases. Arch. Neurol. 50 (1993) 374-379
4. Hardy J., and Gwinn-Hardy K. Genetic classification of primary neurodegenerative disease. Science 282 (1998) 1075-1079
5. Scacchi R., Pinto A., Gambina G., Rosano A., and Corbo R.M. The peroxisome proliferator-activated receptor gamma (PPAR-gamma2) Pro12Ala polymorphism is associated with higher risk for Alzheimer's disease in octogenarians. Brain Res. 1139 (2007) 1-5
6. Koivisto A.M., Helisalmi S., Pihlajamaki J., Hiltunen M., Koivisto K., Moilanen L., Kuusisto J., Helkala E.L., Hanninen T., Kervinen K., Kesaniemi Y.A., Laakso M., and Soininen H. Association analysis of peroxisome proliferator-activated receptor gamma polymorphisms and late onset Alzheimer's disease in the Finnish population. Dement. Geriatr. Cogn. Disord. 22 (2006) 449-453
7. Heneka M.T., and Landreth G.E. PPARs in the brain. Biochim. Biophys. Acta 1771 (2007) 1031-1045
8. Chen G., Chen K.S., Knox J., Inglis J., Bernard A., Martin S.J., Justice A., McConlogue L., Games D., Freedman S.B., and Morris R.G. A learning deficit related to age and beta-amyloid plaques in a mouse model of Alzheimer's disease. Nature 408 (2000) 975-979
9. Janus C., D'Amelio S., Amitay O., Chishti M.A., Strome R., Fraser P., Carlson G.A., Roder J.C., St George-Hyslop P., and Westaway D. Spatial learning in transgenic mice expressing human presenilin 1 (PS1) transgenes. Neurobiol. Aging 21 (2000) 541-549
10. Roberson E.D., Scearce-Levie K., Palop J.J., Yan F., Cheng I.H., Wu T., Gerstein H., Yu G.Q., and Mucke L. Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer's disease mouse model. Science 316 (2007) 750-754
11. Pedersen W.A., McMillan P.J., Kulstad J.J., Leverenz J.B., Craft S., and Haynatzki G.R. Rosiglitazone attenuates learning and memory deficits in Tg2576 Alzheimer mice. Exp. Neurol. 199 (2006) 265-273
12. Leissring M.A., Farris W., Chang A.Y., Walsh D.M., Wu X., Sun X., Frosch M.P., and Selkoe D.J. Enhanced proteolysis of beta-amyloid in APP transgenic mice prevents plaque formation, secondary pathology, and premature death. Neuron 40 (2003) 1087-1093
13. Seta K.A., and Roth R.A. Overexpression of insulin degrading enzyme: cellular localization and effects on insulin signaling. Biochem. Biophys. Res. Commun. 231 (1997) 167-171
14. Selkoe D.J. Clearing the brain's amyloid cobwebs. Neuron 32 (2001) 177-180
15. Farris W., Mansourian S., Chang Y., Lindsley L., Eckman E.A., Frosch M.P., Eckman C.B., Tanzi R.E., Selkoe D.J., and Guenette S. Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo. Proc. Natl. Acad. Sci. USA 100 (2003) 4162-4167
16. Brodbeck J., Balestra M.E., Saunders A.M., Roses A.D., Mahley R.W., and Huang Y. Rosiglitazone increases dendritic spine density and rescues spine loss caused by apolipoprotein E4 in primary cortical neurons. Proc. Natl. Acad. Sci. USA 105 (2008) 1343-1346
17. Heneka M.T., Sastre M., Dumitrescu-Ozimek L., Hanke A., Dewachter I., Kuiperi C., O'Banion K., Klockgether T., Van Leuven F., and Landreth G.E. Acute treatment with the PPARgamma agonist pioglitazone and ibuprofen reduces glial inflammation and Abeta1-42 levels in APPV717I transgenic mice. Brain 128 (2005) 1442-1453
18. Camacho I.E., Serneels L., Spittaels K., Merchiers P., Dominguez D., and De Strooper B. Peroxisome-proliferator-activated receptor gamma induces a clearance mechanism for the amyloid-beta peptide. J. Neurosci. 24 (2004) 10908-10917
19. Du J., Yang X., Zhang L., and Zeng Y.M. Expression of TRPM8 in the distal cerebrospinal fluid-contacting neurons in the brain mesencephalon of rats. Cerebrospinal Fluid Res. 6 (2009) 3
20. Ghiso J., Calero M., Matsubara E., Governale S., Chuba J., Beavis R., Wisniewski T., and Frangione B. Alzheimer's soluble amyloid beta is a normal component of human urine. FEBS Lett. 408 (1997) 105-108
21. Nie K., Yu J.C., Fu Y., Cheng H.Y., Chen F.Y., Qu Y., and Han J.X. Age-related decrease in constructive activation of Akt/PKB in SAMP10 hippocampus. Biochem. Biophys. Res. Commun. 378 (2009) 103-107